All News Silence Therapeutics plc OTC Markets

Equities

SLNCF

GB00B9GTXM62

Market Closed - OTC Markets Other stock markets 08:56:37 08/05/2024 pm IST			5-day change	1st Jan Change
7 ^USD	-12.50%		-12.50%	+366.67%

09/05	European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading	MT
29/04	Silence Therapeutics plc Announces Retirement of Alistair Gray from Board of Directors, Effective May 1, 2024	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading	09/05	MT
Silence Therapeutics to Participate in Fireside Chat at H.C. Wainwright 2nd Annual BioConnect Investor Conference	30/04	BU
Silence Therapeutics Announces Retirement of Alistair Gray from Board of Directors	29/04	BU
Silence Therapeutics plc Announces Retirement of Alistair Gray from Board of Directors, Effective May 1, 2024	29/04	CI
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading But End Week Down	19/04	MT
European Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading	16/04	MT
European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading	15/04	MT
Silence Therapeutics : THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION - Form 6-K	15/04	PU
European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading	12/04	MT
Silence Therapeutics Announces JAMA Publication of Additional Phase 1 Data for Zerlasiran in Subjects with Elevated Lipoprotein(a)	08/04	BU
Silence Therapeutics plc Announces JAMA Publication of Additional Phase 1 Data for Zerlasiran in Subjects with Elevated Lipoprotein(a)	08/04	CI
European Equities Traded in the US as American Depositary Receipts Rise Slightly in Wednesday Trading	27/03	MT
European Equities Traded in the US as American Depositary Receipts Start Week Slightly Lower in Monday Trading	18/03	MT
European Equities Traded in the US as American Depositary Receipts Nudge Lower in Friday Trading	15/03	MT
European Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading	14/03	MT
Chardan Boosts Price Target on Silence Therapeutics to $42 From $26 on Positive Data From Zerlasiran Study, Keeps Buy Rating	14/03	MT
Morgan Stanley Boosts Price Target on Silence Therapeutics to $45 From $29, Says Q4 Showed 'Meaningful Progress,' Keeps Overweight Rating	14/03	MT
European Equities Traded in the US as American Depositary Receipts Nudge Lower in Wednesday Trading	13/03	MT
Silence Therapeutics Says Phase 2 Study of High Lipoprotein(a) Treatment Meets Primary Endpoint	13/03	MT
Sector Update: Health Care Stocks Gain Premarket Wednesday	13/03	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Silence Therapeutics plc OTC Markets

Equities

SLNCF

GB00B9GTXM62

All News

Filters